QureTech Bio Announces the Appointment of Markus Thor as New CEO
QureTech Bio Announces the Appointment of Markus Thor as New [...]
QureTech Bio Announces the Appointment of Markus Thor as New [...]
Scientific publication highlights the potential of GmPcides for treating [...]
QureTech Bio appoints new Chairman of the Board and new [...]
QureTech Bio nominated as ”University Spin-off of the Year” February, [...]
Helén Fält elected Member of the Board of the [...]
QureTech Bio appoints three new board membersMay, 2023At the Annual [...]
Professor Scott Hultgren, co-founder of QureTech Bio, elected member of [...]
Reflections on 2022 from our CEOJanuary, 2023As we enter a [...]
QureTech Bio receives support for development of new antibiotics March, [...]
Reflection from QureTech Bio’s CEO January, 2022 A reflection [...]